ECETOC has released a technical report which provides guidance on the basic requirements of a robust adverse outcome pathway (AOP) – for example, that it is biologically plausible and supported by empirical evidence – with a focus on endocrine disruption.

European Centre for Ecotoxicology and Toxicology of Chemicals (2016). Guidance on assessment and application of adverse outcome pathways (AOPs) relevant to the endocrine system. Technical Report No. 128. http://www.ecetoc.org/wp-content/uploads/2016/12/ECETOC-TR-128-Assessment-and-application-of-AOPs-relevant-to-the-Endocrine-System.pdf

 

The above items were taken from the January/February 2017 issue of Toxicology and Regulatory News which is sent automatically to members of bibra (click here)

News Home Guest Write For Us? Contact Us